122 related articles for article (PubMed ID: 4547961)
21. Comparative ototoxicity of amikacin, gentamicin, netilmicin, and tobramycin in guinea pigs.
Parravicini L; Arpini A; Bamonte F; Marzanatti M; Ongini E
Toxicol Appl Pharmacol; 1982 Sep; 65(2):222-30. PubMed ID: 7179282
[No Abstract] [Full Text] [Related]
22. [Gentamicin and ototoxicity].
Parkhomovskiĭ MA
Vestn Otorinolaringol; 1976; (2):107-11. PubMed ID: 775729
[No Abstract] [Full Text] [Related]
23. Middle ear instillation of gentamicin and streptomycin in chinchillas: morphologic appraisal of selective ototoxicity.
Chen JM; Kakigi A; Hirakawa H; Mount RJ; Harrison RV
J Otolaryngol; 1999 Jun; 28(3):121-8. PubMed ID: 10410341
[TBL] [Abstract][Full Text] [Related]
24. Vestibular and cochlear ototoxicity of topical antiseptics assessed by evoked potentials.
Perez R; Freeman S; Sohmer H; Sichel JY
Laryngoscope; 2000 Sep; 110(9):1522-7. PubMed ID: 10983954
[TBL] [Abstract][Full Text] [Related]
25. Experimental ototoxicity of gentamicin in squirrel monkeys.
Igarashi M; Lundquist PG; Alford BR; Miyata H
J Infect Dis; 1971 Dec; 124 Suppl():S114-24. PubMed ID: 5001618
[No Abstract] [Full Text] [Related]
26. [Cochleo-vestibular tolerance for new aminoglucoside antibiotics].
Conraux C; Collard M; Brogard JM; Lavillaureix J
Rev Otoneuroophtalmol; 1975; 47(2):67-9. PubMed ID: 1082162
[No Abstract] [Full Text] [Related]
27. Iron chelators protect from aminoglycoside-induced cochleo- and vestibulo-toxicity.
Song BB; Sha SH; Schacht J
Free Radic Biol Med; 1998 Jul; 25(2):189-95. PubMed ID: 9667495
[TBL] [Abstract][Full Text] [Related]
28. [Reversible nonfunctioning of the vestibular apparatus following gentamicin].
Witzel L
Munch Med Wochenschr; 1970 Dec; 112(52):Suppl 52:2. PubMed ID: 5312809
[No Abstract] [Full Text] [Related]
29. Cochlear and Vestibular Effects of Combined Intratympanic Gentamicin and Dexamethasone.
Güneri EA; Olgun Y; Aslıer M; Nuti D; Kırkım G; Mungan S; Kolatan E; Aktaş S; Trabalzini F; Ellidokuz H; Yılmaz O; Mandala M
J Int Adv Otol; 2017 Apr; 13(1):47-52. PubMed ID: 28084995
[TBL] [Abstract][Full Text] [Related]
30. Gentamicin concentration and toxicity.
Modi N; Maggs AF; Clarke C; Chapman C; Swann RA
Lancet; 1998 Jul; 352(9121):70. PubMed ID: 9800783
[No Abstract] [Full Text] [Related]
31. [Experimental labyrinth damage by gentamicin. I. Functional data].
Bernabei L; Pierangeli CE; Di Brino M; Consalvo P
Atti Accad Fisiocrit Siena Med Fis; 1967; 16(1):445-67. PubMed ID: 5310658
[No Abstract] [Full Text] [Related]
32. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
Kaplan DM; Hehar SS; Bance ML; Rutka JA
Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
[TBL] [Abstract][Full Text] [Related]
33. Gentamicin sulphate.
S Afr Med J; 1968 Jan; 42(1):1. PubMed ID: 5300701
[No Abstract] [Full Text] [Related]
34. [Cochleovestibular disorders during treatment with dihydrostreptomycin].
DECROIX G; CROISIER J
Echo Med Nord; 1955 Apr; 26(4):195-200. PubMed ID: 13251160
[No Abstract] [Full Text] [Related]
35. Tuning in to ototoxicity. The inside story.
Haybach PJ
Nursing; 1993 Jun; 23(6):34-41. PubMed ID: 8510836
[No Abstract] [Full Text] [Related]
36. [Iatrogenic pathology in otorhinolaryngology].
Rebattu JP; Lafon H; Cajgfinger H
JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1972 Dec; 21(10):931-5. PubMed ID: 4265738
[No Abstract] [Full Text] [Related]
37. Clinical research experience with gentamicin. Incidence of adverse reactions.
Arcieri GM; Falco FG; Smith HM; Hobson LB
Med J Aust; 1970 Jun; 1():Suppl:30-4. PubMed ID: 5311183
[No Abstract] [Full Text] [Related]
38. [Effect of streptomycin on the cochlear and vestibular apparatus. Studies on 110 children following antitubercular therapy].
Gekle D; Aguigah G; Essler H; Schnieder EA
Klin Padiatr; 1973 Jan; 185(1):22-31. PubMed ID: 4540235
[No Abstract] [Full Text] [Related]
39. [Treatment of gonorrhea in women using a single gentamicin administration].
Bartunek J; Kraft D; Mayer-Hausner E
Hautarzt; 1974 Dec; 25(12):622-4. PubMed ID: 4448645
[No Abstract] [Full Text] [Related]
40. A proposed protocol for monitoring ototoxicity in patients who take cochleo- or vestibulotoxic drugs.
Vasquez R; Mattucci KF
Ear Nose Throat J; 2003 Mar; 82(3):181-4. PubMed ID: 12696237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
